- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04836039
Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak
Evaluation of Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak
연구 개요
상세 설명
The aim of this study is to evaluate the process experienced by physiotherapists while providing rehabilitation services during the epidemic and to investigate the procedures adopted by physiotherapists who are currently working.
In addition, by analyzing the effects of both the pandemic and the clinical and educational organizations in the Physiotherapy and Rehabilitation Clinics where physiotherapists were working during the COVID-19 epidemic, the needs arising after the pandemic can be reported.
Assessments will be carried out by researcher physiotherapists through a questionnaire based on research and examples in the literature, and scales measuring anxiety, depression and stress levels. The measurement tool will be the online survey application.
Data collection is planned to take place in February-March 2021.
Surveys will be distributed via WhatsApp, e-mail, social media links. This questionnaire was sent to 3 physiotherapists and subjected to a pre-test. This questionnaire is about the following situations and contains 37 questions:
Information on employment status: In this section, physiotherapists' name-surname, gender, age, professional practice experience (years), generally applied physiotherapy subgroup (more than one can be selected), whether they are self-employed or employees, and the status of performing face-to-face clinical practices will be questioned. If so, it will be questioned which protection measures have been applied.
Information about tele-rehabilitation practices: In this section, it will be questioned whether physiotherapists start to follow their patients remotely, if they are, in what way they do it, whether the number of weekly sessions continues, and whether the amount collected is the same as the face-to-face amount.
General information about COVID 19 rehabilitation: In this section, did the departments where physiotherapists work returned to COVID 19 services, did they work in COVID 19 units, rehabilitation approaches in COVID 19 patients, protocol and / or guidelines on exercises for rehabilitation management and treatment of COVID 19 patients. material development / implementation status will be questioned.
The impact of the pandemic on the health and teaching activities of physiotherapists and the sustainability of clinical / thesis studies during this period will be questioned.
Finally, the CES Depression Scale (Center for Epidemiologic Studies Depression Scale, CES-D) will be used to determine depression level, the Generalized Anxiety Disorder 7 (GAD-7) Test will be used to evaluate generalized anxiety level, Perceived Stress Scale (PSS) will be used to determine stress level.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
Beykoz
-
Istanbul, Beykoz, 칠면조, 34815
- Medipol University
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.
Exclusion Criteria:
Not meeting the inclusion criteria
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: 보병대
- 시간 관점: 회고전
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Physiotherapists
Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.
|
Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
A questionnaire created by research physiotherapists based on researches and examples in the literature.
기간: The evaluation will take place in one interview (the interview will take 30 minutes)
|
Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Assessment of depression level with Center for Epidemiologic Studies Depression Scale
기간: The evaluation will take place in one interview (the interview will take 30 minutes)
|
The Center for Epidemiologic Studies Depression Scale will be used to determine depression level.
The scale consists of 20 questions in the form of a self-report that measure the emotional state of the person in depression, perceptions and behaviors towards depression.
4-point Likert type questionnaire with 0-60 points range is encoded in 0-3 points range.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
|
Assessment of anxiety level with Generalized Anxiety Disorder 7 Test
기간: The evaluation will take place in one interview (the interview will take 30 minutes)
|
The Generalized Anxiety Disorder 7 test will be used to determine anxiety level.
It is a 7-item four-point Likert (0 = none, 1 = many days, 2 = more than half of the days, 3 = almost every day), which evaluates the experiences asked in the scale items in the last 2 weeks.
The total scores obtained from the scale are 5, 10, and 15 cut-off points for mild, moderate, and severe anxiety, respectively.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
|
Assessment of stress level with Perceived Stress Scale
기간: The evaluation will take place in one interview (the interview will take 30 minutes)
|
Perceived Stress Scale will be used to determine stress level.
Participants rate how often their lives were seen as unpredictable, uncontrollable, and overly intense during the previous month on the 5-point Likert scale (0 = Never, 4 = Very often).
Total scores range from 0 to 40, with higher scores indicating a higher perceived stress level.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
공동 작업자 및 조사자
수사관
- 연구 의자: Gülay Aras Bayram, asAss. Prof., Medipol University
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- E-10840098-772.02-2682
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .